Received Sep 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | IM |
swelling of the arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling of the arm) in a 70-year-old female patient who received mRNA-1283 (MNEXSPIKE PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 13-Sep-2025, the patient received dose of mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swelling of the arm). At the time of the report, PERIPHERAL SWELLING (swelling of the arm) outcome was unknown. The action taken with mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use) was unknown. No concomitant medications were reported. The patient did not experience any side effects from mNEXSPIKE vaccine except for swelling of the arm. She wanted to know if it was advisable to take another booster since the vaccine she received was a lower dose. It was unknown if the patient experienced any additional symptoms/events. No treatment information was provided.